Ketamine Update with Brandon Kitay, M.D.
1/27/2022
Copy link to Clipboard

Ketamine Update with Brandon Kitay, M.D.

Esketamine is the first non-monoaminergic based medication which is FDA approved and indicated for treatment refractory depression. A longer duration of undertreated depression is associated with poor longitudinal functional outcomes. Instead of cycl...

More details
Bullhorn
(519)

Get Started

Download the App